Fig. 1 · Structure
Documents & Downloads
Chenodeoxycholic acid sodium
Cat. No.
A39369
CAS
2646-38-0
Endogenous Metabolite
Chenodeoxycholic acid sodium is a hydrophobic primary bile acid that predominantly activates farnesoid X receptor (FXR), a nuclear receptor integral to cholesterol metabolism and homeostasis. This compound plays a significant role in regulating lipid metabolism and has been implicated in therapeutic applications related to metabolic disorders, particularly in studies investigating the modulation of bile acid signaling pathways. Its ability to influence liver function and glucose metabolism makes it a valuable reagent in biological research focused on metabolic regulation and associated pathologies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2646-38-0 |
| Applications | Endogenous Metabolite |
| Formula | C24H39NaO4 |
| Molecular Weight | 414.55 |
| Synonyms | CDCA sodium |
| SMILES | O=C(O[Na])CC[C@@H](C)[C@]1([H])[C@]2(C)[C@](CC1)([H])[C@]3([H])[C@H](O)C[C@@](C4)([H])[C@@](CC[C@H]4O)(C)[C@]([H])3CC2 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.